EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ARNT2-driven transcriptional activation of STRA6 reprograms fatty acid metabolism to promote retroperitoneal liposarcoma progression

Junxiang Zhang, Hainan Guo, Bo Ban, Lin Yang, Jie Lian, Gan Li, Lindi Cai, Kai Deng, He Jiang, Xuqi Li, Shufeng Wang

Journal of Cancer Research and Clinical Oncology · 2025

DOI: 10.1007/s00432-025-06352-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2025. Verfasst von Junxiang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, China. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Fatty Acids, Transcriptional Activation, Liposarcoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Plan of Shaanxi Province, Fundamental Research Funds for Xi'an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Retroperitoneal liposarcoma (RLPS) is a mesenchymal-derived malignant tumor characterized by high aggressiveness and a propensity for local recurrence. Emerging evidence implicates aberrant fatty acid metabolism as a key driver of RLPS progression, yet the transcriptional regulators orchestrating this process remain poorly defined. METHODS: Bioinformatics integrating cellular experiments demonstrated the role of fatty acid metabolism in the progression of RLPS. Immunohistochemistry (IHC) and Western blotting (WB) were employed to validate the expression levels of ARNT2, and the role of ARNT2 in tumor progression was demonstrated through CCK8 assays, Transwell invasion assays and wound healing assays. Further experiments confirmed the transcriptional regulatory effect of ARNT2 on STRA6 and demonstrated its control over RLPS progression by modulating intracellular lipid droplet and triglyceride levels. RESULTS: Here, we identify ARNT2 as a novel oncogenic transcription factor that promotes RLPS growth by transcriptionally upregulating STRA6, thereby reprogramming fatty acid metabolism. Specifically, ARNT2 binds to the STRA6 promoter to enhance its activity, thereby upregulating fatty acid metabolic enzymes and promoting lipid droplet accumulation with elevated triglycerides. This metabolic shift fuels energy production and biomass synthesis in RLPS cells, ultimately accelerating tumor proliferation and invasion. CONCLUSION: This study identifies ARNT2 as a transcriptional modulator of fatty acid metabolism pathways, highlighting its potential as a viable molecular target for RLPS therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsFatty AcidsTranscriptional ActivationLiposarcomaAryl Hydrocarbon Receptor Nuclear TranslocatorMembrane ProteinsHumansDisease ProgressionGene Expression Regulation, NeoplasticMiceAnimalsCell ProliferationCell Line, TumorMale

Stichwörter der Autor:innen

Fatty acid metabolismRetroperitoneal liposarcomaSoft tissue sarcomaTranscriptional regulation

Substanzen

Basic Helix-Loop-Helix ProteinsFatty AcidsAryl Hydrocarbon Receptor Nuclear TranslocatorMembrane ProteinsARNT2 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, China.
  • Department of Breast Surgery, The Tumor Hospital of Shaanxi Province, Xi'an, 710061, Shaanxi Province, China.
  • Department of Pathology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, China.
  • Department of Hepatobiliary Surgery, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
  • Department of General Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, China. lixuqi@163.com.
  • Department of General Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, China. wangshufeng0105@163.com.

Förderung

  • Key Research and Development Plan of Shaanxi Province
  • Fundamental Research Funds for Xi'an Jiaotong University

Zitieren

APA

Zhang, J., Guo, H., Ban, B., Yang, L., Lian, J., Li, G., Cai, L., Deng, K., Jiang, H., Li, X., & Wang, S. (2025). ARNT2-driven transcriptional activation of STRA6 reprograms fatty acid metabolism to promote retroperitoneal liposarcoma progression. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-025-06352-1

Vancouver

Zhang J, Guo H, Ban B, Yang L, Lian J, Li G, et al. ARNT2-driven transcriptional activation of STRA6 reprograms fatty acid metabolism to promote retroperitoneal liposarcoma progression. Journal of Cancer Research and Clinical Oncology. 2025. doi:10.1007/s00432-025-06352-1

BibTeX
@article{Zhang2025,
  author = {Zhang, Junxiang and Guo, Hainan and Ban, Bo and Yang, Lin and Lian, Jie and Li, Gan and Cai, Lindi and Deng, Kai and Jiang, He and Li, Xuqi and Wang, Shufeng},
  title = {ARNT2-driven transcriptional activation of STRA6 reprograms fatty acid metabolism to promote retroperitoneal liposarcoma progression},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2025},
  doi = {10.1007/s00432-025-06352-1}
}
Kostenlos starten →